Series Introduction: The transcription factor NF-κB and human disease
Top Cited Papers
Open Access
- 1 January 2001
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 107 (1) , 3-6
- https://doi.org/10.1172/jci11891
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- A potential role of activated NF-κB in the pathogenesis of euthyroid sick syndromeJournal of Clinical Investigation, 2000
- Control of apoptosis by Rel/NF-κB transcription factorsOncogene, 1999
- Aberrant rel/nfkb genes and activity in human cancerOncogene, 1999
- Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor-α-induced HIV-1 replication in latently infected OM10.1 and Ach2 cellsInternational Immunology, 1999
- Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-κBOncogene, 1999
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Requirement for NF-κB in osteoclast and B-cell developmentGenes & Development, 1997
- The role of Rel/NF-κB proteins in viral oncogenesis and the regulation of viral transcriptionSeminars in Cancer Biology, 1997
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Expression of a constitutive NF-kappa B-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells.Journal of Clinical Investigation, 1995